论文部分内容阅读
目的分析肺泡表面活性物质(PS)及盐酸氨溴索治疗新生儿呼吸窘迫综合征的疗效比较。方法 90例呼吸窘迫综合征患儿随机分成两组,治疗组45例,在常规治疗基础上,加用肺泡表面活性物质;对照组45例,基础治疗加盐酸氨溴索。结果治疗组效果明显高于对照组,吸氧时间及住院时间均短于对照组,有效率明显高于对照组。结论肺泡表面活性物质能明显提高新生儿呼吸窘迫综合征的治愈率,降低死亡率,缩短住院时间。
Objective To compare the efficacy of alveolar surfactant (PS) and ambroxol hydrochloride in neonatal respiratory distress syndrome. Methods Ninety children with respiratory distress syndrome were randomly divided into two groups. The treatment group consisted of 45 patients. On the basis of routine treatment, alveolar surfactant was added. In the control group, 45 patients were treated with ambroxol hydrochloride. Results The treatment group was significantly higher than the control group, oxygen inhalation time and hospitalization were shorter than the control group, the effective rate was significantly higher than the control group. Conclusion The alveolar surfactant can obviously improve the cure rate of neonatal respiratory distress syndrome, reduce the mortality and shorten the length of hospital stay.